Cypress Capital Group Purchases 373 Shares of CME Group Inc. (NASDAQ:CME)

Cypress Capital Group raised its position in CME Group Inc. (NASDAQ:CME) by 1.1% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 34,190 shares of the financial services provider’s stock after purchasing an additional 373 shares during the period. CME Group accounts for 0.8% of Cypress Capital Group’s holdings, making the stock its 29th biggest position. Cypress Capital Group’s holdings in CME Group were worth $7,544,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of the company. Ameriprise Financial Inc. increased its position in CME Group by 11.3% in the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock worth $1,038,676,000 after buying an additional 537,758 shares during the last quarter. GUARDCAP ASSET MANAGEMENT Ltd raised its stake in CME Group by 1.1% in the 1st quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 4,009,068 shares of the financial services provider’s stock valued at $863,112,000 after acquiring an additional 43,293 shares during the period. Raymond James & Associates lifted its holdings in CME Group by 3.2% during the second quarter. Raymond James & Associates now owns 3,029,145 shares of the financial services provider’s stock valued at $595,530,000 after purchasing an additional 94,302 shares during the last quarter. Legal & General Group Plc boosted its position in CME Group by 6.6% during the second quarter. Legal & General Group Plc now owns 2,835,075 shares of the financial services provider’s stock worth $557,371,000 after purchasing an additional 176,004 shares during the period. Finally, PineStone Asset Management Inc. increased its stake in shares of CME Group by 137.6% in the second quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock worth $444,443,000 after purchasing an additional 1,309,097 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Trading Down 0.7 %

NASDAQ:CME opened at $228.00 on Thursday. The firm has a market capitalization of $82.16 billion, a P/E ratio of 23.97, a P/E/G ratio of 5.30 and a beta of 0.55. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $230.74. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The company has a fifty day moving average of $223.21 and a 200 day moving average of $210.81.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The company had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period in the prior year, the business posted $2.25 earnings per share. CME Group’s revenue for the quarter was up 18.4% on a year-over-year basis. On average, research analysts predict that CME Group Inc. will post 10.22 earnings per share for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be issued a $1.15 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.60 annualized dividend and a yield of 2.02%. CME Group’s dividend payout ratio (DPR) is presently 48.37%.

Wall Street Analysts Forecast Growth

CME has been the subject of a number of recent research reports. Oppenheimer lifted their price objective on shares of CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research note on Thursday, October 24th. TD Cowen assumed coverage on CME Group in a report on Thursday, September 26th. They set a “hold” rating and a $221.00 target price for the company. The Goldman Sachs Group increased their price target on shares of CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a report on Thursday, October 3rd. Royal Bank of Canada reissued a “sector perform” rating and set a $235.00 price objective on shares of CME Group in a research note on Thursday, October 24th. Finally, Piper Sandler boosted their price target on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research note on Monday, October 28th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $224.47.

Insider Activity at CME Group

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This trade represents a 12.01 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction dated Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. The trade was a 5.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,621 shares of company stock worth $3,441,063 over the last 90 days. 0.30% of the stock is owned by company insiders.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.